The Food and Drug Administration (FDA) has expanded the approval of Furoscix® (furosemide injection) to include the treatment of edema in patients with ...
Furoscix is expected to be available for CKD patients in April 2025. The Food and Drug Administration (FDA) has expanded the approval of Furoscix ® (furosemide injection) to include the treatment ...
Last week’s significant research news included positive new Phase III data on Tezspire in nasal polyps from Amgen and ...
Its lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion due to fluid overload in adults with ...
Its lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion due to fluid overload in adults with ...
(Politico) The FDA expanded the approval of furosemide (Furoscix) to include treatment of edema in adults with chronic kidney disease, drugmaker scPharmaceuticals announced. Pope Francis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback